Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof
Reexamination Certificate
2006-10-17
2006-10-17
Ewoldt, G. R. (Department: 1644)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Monoclonal antibody or fragment thereof
C424S139100, C435S326000, C435S344100, C530S388900
Reexamination Certificate
active
07122184
ABSTRACT:
The invention concerns momoclonal antibodies to terbinafine in free base or salt form, immunogenic conjugates suitable for preparing them, hybridoma capable of producing them, and corresponding assay kits. The antibodies can be prepared by administering to an appropriate animal an immunogenic conjugate of a suitable derivative of terbinafine covalently linked to an immonogen, recovering antibody-producing cells sensitized to the conjugate, immortalizing the antibody-producing cells, selecting a resultant immortalized cell line, and recovering the resultant antibodies therefrom. They are indicated for use in particular in the measurement of terbinafine tissue concentration and distribution in bodily fluids or compartments, especially nails.
REFERENCES:
patent: 5169773 (1992-12-01), Rosenthaler et al.
patent: 5817875 (1998-10-01), Karimian et al.
patent: 3316093 (1983-11-01), None
patent: 2 256 139 (1992-12-01), None
patent: WO 94/20082 (1994-09-01), None
patent: WO 94/23018 (1994-10-01), None
patent: WO 97/49732 (1997-12-01), None
Campbell, A. “Monoclonal Antibody Technology” (1984) Elsevier Science Publishing Company, Inc., pp. 1-32.
Stewart et al., “Titering antibodies” in Current Protocols in Cytometry, (1997) John Wiley and Sons, 4.1.1-4.1.13.
The Immunoassay Handbook, second edition, edited by David Wild (2001) Nature Publishing Group, pp. 83-89.
Janeway et al., Immunobiology,3rdedition 1997, Garland Publishing Inc., pp. 2:2-2:4, 2:17, and 2:18.
Kuby et al., “Immunology”, 1992, W. H. Freeman and Company, p. 125.
Köhler et al., “Continuous Cultures of Fused Cells secreting Antibody of Predefined Specificity”,Nature,vol. 256, pp. 495-497 (1975).
Battig et al., “Pharmacokinetics and Biotransformation of the14C-Labeled Drug in Laboratory Animals and Man”,Proc. Int. Congr. Chemother., 13th, Part 116, pp. 37-40 (1983).
Stütz et al., “Synthesis and Antifungal Activity of (E)-N-(6,6-Dimethyl-2-hepten-4-ynyl)-N-methyl-1-napththalenemethanamine (SF-86-327) and Related Allylamine Derivatives with Enhanced Oral Activity”,J. Med. Chem.,vol. 27, pp. 1539-1543 (1984).
Schuster, “Metabolic Degradation of Terbinafine in Liver Microsomes from Man, Guinea Pig and Rat”, In: Recent Trends in the Discovery, Development and Evaluation of Antifungal Agents, Fromtling, Editor, J.R. Prous Science Publishers S.A., Barcelona, pp. 461-470 (1987).
Battig et al., “Major Biotransformation Routes of Some Allylamine Antimycotics”, In: Recent Trends in the Discovery, Development and Evaluation of Antifungal Agents, Fromtling, Ed., J.R. Prous Science Publishers S.A., Barcelona, pp. 479-495 (1987).
Schatz et al., “Analytical Methods for the Determination of Terbinafine and Its Metabolites in Human Plasma, Milk and Urine”, Drug Res., vol. 39, Suppl. I, No. 4, pp. 527-532 (1989).
Nussbaumer et al., “Allylamine Antimycotics: Recent Trends in Structure-Activity Relationships and Syntheses”,Pestic. Sci.,vol. 31, pp. 437-455 (1991).
The Immunoassay Handbook, Concepts 89, “Cross-Reactivity”.
Denouël et al., “Determination of Terbinafine and Its Desmethyl Metabolite in Human Plasma by High-Performance Liquid Chromatography”,J. Chromatogr. B.,vol. 663, pp. 353-359 (1995). (XP-002168314).
Watanabe et al., “Development of a Competitive Enzyme-Linked Immunosorbent Assay Based on a Monoclonal Antibody for a Fungicide Flutolanil”,Analytica. Chimica. Acta.,vol. 376, pp. 93-96 (1998).
Instructions, “Imject® Carboxyl Reactive Antibody Production & Purification Kits with KLH, BSA or OVA”, Pierce, Rockford, IL, pp. 1-7 (1999). (XP-002168315).
Machard et al., “A Sensitive Amphotericin B Immunoassay for Pharmacokinetic and Distribution Studies”, Antimirobial Agents and Chemotherapy, vol. 44, pp. 546-550 (2000). (XP-000999851).
Watanabe et al., “Development of an Enzyme-Linked Immunosorbent Assay for the Fungicide Imazalil in Citrus Fruits”,J. Agric. Food Chem.,vol. 48, pp. 5124-5130 (2000).
Watanabe et al., “Immunoaffinity Column Clean-Up for the Determination of Imazalil in Citrus Fruits”,Analytica. Chimica. Acta.,No. 433, pp. 199-206 (2001).
Derwent Abstract AN 1998-077113, Bizzini et al., WO 9749732, Jun. 26, 1997.
Derwent Abstract AN 1998-560719, Kenkyusho, JP 10248565A, Mar. 18, 1997.
Derwent Abstract AN 1993-284687, JP 05199894 A, Aug. 20, 1990.
Chemical Abstracts, vol. 104, pp. 11434-11435 (1986).
Dorobek Birgit
Nussbaumer Peter
Ewoldt G. R.
Houghton Gregory C.
Novartis AG
Szperka Michael
LandOfFree
Specific monoclonal antibody against terbinafine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Specific monoclonal antibody against terbinafine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Specific monoclonal antibody against terbinafine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3653216